Innovative Biopharmaceutical Association (IBA) – USA is a nonprofit organization home-based in Greater Philadelphia and dedicated to advancing the communication, translation, and commercialization of cutting-edge scientific discoveries and pharmaceutical R&D innovations.

创新生物医药协会（IBA）- USA 是一家总部位于大费城地区的非营利组织，致力于推动前沿科学发现与生物医药研发创新的交流、转化与产业化。

IBA primarily serves U.S.-based academic investigators and biopharmaceutical companies, with a mission to build a high-level national platform that fosters drug development through active engagement of scientists, clinical experts, entrepreneurs, and venture capital partners across the United States.

IBA 主要服务于美国本土的学术研究者与生物医药企业，其使命是打造一个高水平的全国性平台，通过全美范围内科学家、临床专家、创业者与风险投资伙伴的积极参与，推动新药研发进程。

IBA was founded in 2025 by the core leadership team of the former CBA-GP, and continues that community's tradition of scientific exchange and gathering.

IBA 于 2025 年由原 CBA-GP 管理团队核心班底创立，并延续了这一社区在学术交流与聚会方面的传统。